Skip to content

VascTrac Peripheral Arterial Disease (PAD) Study

VascTrac PAD ResearchKit Study

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03048890
Acronym
VascTrac
Enrollment
2000
Registered
2017-02-09
Start date
2017-03-01
Completion date
2023-12-01
Last updated
2022-11-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Peripheral Artery Disease, Intermittent Claudication

Keywords

PAD

Brief summary

VascTrac is a mobile medical application that tracks users' physical activity levels in order to predict endovascular failure of patients with Peripheral Artery Disease.

Detailed description

VascTrac uses open-source software from Apple's ResearchKit to passively track physical activity levels of users who sign up. The goal is to predict post-intervention endovascular failure before it occurs. Currently, physicians have no way of knowing when procedures such as angioplasties fail; with VascTrac, researchers hope to find downward trends in physical activity that will predict and indicate endovascular failure. All users are assigned numbers and their medical data is securely coded, decreasing the risk of promulgation of personal information.

Interventions

Patients with severely low physical activity levels will be notified to consult their physician.

Sponsors

W.L.Gore & Associates
CollaboratorINDUSTRY
Abbott
CollaboratorINDUSTRY
Cook Group Incorporated
CollaboratorINDUSTRY
Boston Scientific Corporation
CollaboratorINDUSTRY
Palo Alto Veterans Institute for Research
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* adult, has iPhone 5s, can read English

Exclusion criteria

* under 18 years

Design outcomes

Primary

MeasureTime frameDescription
Physical ActivityTwo YearsParticipants will have their physical activity measured and recorded by the devices in Apple's Health application.

Countries

United States

Contacts

Primary ContactOliver O Aalami, MD
aalami@stanford.edu650-852-3451

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026